Compositions and Methods for Treatment and Prevention of Neurological Disorders

The European Patent Office published patent EP4165025A2 granted to Yumanity Therapeutics, Inc. covering compositions and methods for treating neurological disorders. The patent claims cover specific chemical compounds classified under A61K 31/5377 and A61K 31/519 with applications for neurological conditions including A61P 25/28. The patent is validated in designated European member states including Germany, France, United Kingdom, Italy, and Spain.

Boston Scientific left atrial appendage implant, published 1st Apr

Boston Scientific left atrial appendage implant, published 1st Apr

Cochlear implant drug delivery system, EP3684456A2

The European Patent Office published patent application EP3684456A2 by Cochlear Limited for an implantable therapeutic substance delivery system designed for cochlear implants. The system enables localized delivery of therapeutic substances to the inner ear through an implanted device. The application covers designated states across the European Economic Area.

Ophthalmic System Including Accommodating Intraocular Lens and Remote Component

The European Patent Office published patent EP3876868A1 for Verily Life Sciences LLC covering an ophthalmic system with an accommodating intraocular lens and remote component. The patent was published on April 1, 2026, with A61F 2/16 classification. The patent grants intellectual property protection across 31 EPO designated member states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Release Therapeutics SA Sustained-Release Implant Capsule

The European Patent Office granted patent EP4013381A1 to Release Therapeutics SA, Les Hôpitaux Universitaires de Genève, and Université de Genève for an implantable capsule designed for sustained-release drug delivery. The invention covers the capsule structure and composition with applications in medical treatment delivery.

Methods and Systems for Controlling a Prosthetic or Orthotic Device

The European Patent Office granted Össur Iceland EHF Patent EP4031074A1 covering methods and systems for controlling prosthetic or orthotic devices. The patent names inventors Einarsoon Arni and Langlois David with IPC classifications spanning A61F 2/50 through A61F 2/76. The patent is designated across 31 European states including DE, FR, GB, IT, ES, NL, SE, and CH.

Carl Zeiss Intraocular Lens Implant Patent EP4213767A1

Carl Zeiss intraocular lens implant, EP4213767A1, published 1st Apr

High Definition and Extended Depth of Field Intraocular Lens

The European Patent Office granted Patent EP4076281A1 to Z Optics, Inc. for a high definition and extended depth of field intraocular lens design. The patent covers optical engineering innovations in intraocular lens technology and is designated for all 31 European Patent Convention member states.

STEM FOR ARTIFICIAL JOINT AND METHOD FOR MANUFACTURING SAME

The European Patent Office published patent EP4129242A1 for a stem component for artificial joints, assigned to Saga University and Kyocera Medical Corporation. The patent covers the design and manufacturing method for artificial joint stems. Protection extends across EU member states plus additional European countries designated in the filing.

Cephea Valve Delivery System - Heart Valve Replacement

The European Patent Office published EP4138729A2 for Cephea Valve Technologies, Inc., covering a delivery system for heart valve replacement. The patent application was filed with claims related to A61F 2/24 (heart valve prostheses) and A61M 25/01 (catheter placement). The patent designates all EU member states plus Switzerland, Norway, and Turkey.